José J. Rifón Roca

Statistics

Publications

Citations

675

H-Index

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Clinica Universidad de Navarra

Centre Hospitalier Universitaire de Toulouse

University Hospital Schleswig-Holstein

Ospedale Papa Giovanni XXIII

José J. Rifón Roca is an author at The University of Texas MD Anderson Cancer Center specializing in lymphoid neoplasms, medicine, and hematologic malignancy therapy.

Publications per year

2017–2024

Publications

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 580 citations

Medicine, Hematology, Oncology +12

Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia

Elias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal et al. · American Journal of Hematology · 2024 · 64 citations · Full text

Medicine, Immunology, Oncology +14

CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome

Paula Rodríguez-Márquez, María Eréndira Calleja-Cervantes, Guillermo Serrano et al. · Blood · 2021 · 16 citations · Full text

Life Sciences, Immunology, Oncology +16

Safety and Pharmacokinetics of Subcutaneous Blinatumomab (SC blinatumomab) for the Treatment of Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL); Results from a Phase 1b Study

Pilar Martínez‐Sánchez, Gerhard Zugmaier, Paul Gordon et al. · Blood · 2022 · 15 citations

Medicine, Pharmacokinetics, Pharmacology +14

1–4 of 4